![Noah Goodman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Noah Goodman
Corporate Officer/Principal at
KYMERA THERAPEUTICS, INC.
Net worth: 5 M $ as of 30/06/2026
Profile
Mr. Noah Goodman is a Chief Business Officer at Kymera Therapeutics, Inc. Mr. Goodman was previously employed as a President & Chief Business Officer by Chroma Medicine, Inc., an Executive Director & Head-Business Development by Cadent Therapeutics, Inc., and a Head-Business Development by Spark Therapeutics, Inc. He received his undergraduate degree from the University of Michigan and an MBA from The Wharton School of the University of Pennsylvania.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 01/07/2026 | 47,179 ( 0.06% ) | 5 M $ | 30/06/2026 |
Noah Goodman active positions
| Companies | Position | Start |
|---|---|---|
| KYMERA THERAPEUTICS, INC. | Corporate Officer/Principal | 09/04/2025 |
Former positions of Noah Goodman
| Companies | Position | End |
|---|---|---|
Chroma Medicine, Inc.
 Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Manufactures genomic medicines | President | 01/04/2025 |
Cadent Therapeutics, Inc.
 Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders | Director/Board Member | 01/03/2021 |
| SPARK THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2019 |
Training of Noah Goodman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
14
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cadent Therapeutics, Inc.
Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Develops therapy products for debilitating diseases | Health Technology |
Kymera Therapeutics, Inc.
 Kymera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunology medicines for health problems | Health Technology |
Chroma Medicine, Inc.
Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Manufactures genomic medicines | Health Technology |
- Stock Market
- Insiders
- Noah Goodman
